115 related articles for article (PubMed ID: 2993873)
1. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
Kaplan J; Shope TC
Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation.
Arai S; Yamamoto H; Itoh K; Kumagai K
J Immunol; 1983 Aug; 131(2):651-7. PubMed ID: 6223088
[TBL] [Abstract][Full Text] [Related]
4. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
[TBL] [Abstract][Full Text] [Related]
5. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
6. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.
Brieva JA; Targan S; Stevens RH
J Immunol; 1984 Feb; 132(2):611-5. PubMed ID: 6228592
[TBL] [Abstract][Full Text] [Related]
7. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
8. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
[TBL] [Abstract][Full Text] [Related]
9. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
Froelich CJ; Guiffaut S
J Immunol; 1987 Dec; 139(11):3637-43. PubMed ID: 2824611
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
12. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
13. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
14. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
Wang F; Blaese RM; Zoon KC; Tosato G
J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
16. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
17. Surface antigen determinants in subpopulations of peripheral blood NK- and T-cells separated by Percoll density fractionation.
Schlesinger M; Lew F; Bekesi JG
J Clin Lab Immunol; 1984 Apr; 13(4):195-202. PubMed ID: 6204054
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
Zarling JM; Bach FH; Kung PC
J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
